Researchers track blood clotting risks in children receiving leukemia treatment

A new study examines how blood clotting changes in children undergoing early-stage acute lymphoblastic leukemia treatment with the ALLTogether protocol. Understanding these haemostasis complications could improve treatment protocols and reduce hospitalizations, affecting clinical outcomes and healthcare costs for pediatric oncology programs.

Originaltitel: Haemostasis during early treatment of childhood acute lymphoblastic leukaemia with the ALLTogether protocol